The effects of a traditional medicine, Fang-ji-huang-qi-tang (Boi-ogi-to), on urinary sugar and sugar alcohols in streptozotocin-induced diabetic mice

Journal of Health Science

Volumn 48, Issue 2, 2002, Pages 168-172

  Liu, Yuan Ying ^a   Tsutsumi, Taiki ^a   Zhang, Chunhua ^b   Matsumoto, Isamu ^b  

^a HOKURIKU UNIVERSITY   (Japan)

^b Ni65 1 Otomo machi 920 0222   (Japan)

Author keywords

Antihyperglycemic effect; Diabetes; Fang ji huang qi tang; Polyol pathway; Sugar; Sugar alcohol

Indexed keywords

1,5 ANHYDROSORBITOL; ANTIDIABETIC AGENT; FANG JI HUANG QI TANG; FRUCTOSE; GINGER EXTRACT; GLUCOSE; GLYCYRRHIZA EXTRACT; INOSITOL; PLANT MEDICINAL PRODUCT; POLYOL; SORBITOL; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; MALE; MOUSE; NONHUMAN; STREPTOZOCIN DIABETES;

ANIMALIA; ASTRAGALI RADIX; ATRACTYLODES; FRUCTUS; GLYCYRRHIZA; GLYCYRRHIZAE RADIX; RHIZOMA; STEPHANIA; ZINGIBER OFFICINALE; ZINGIBERIS RHIZOMA;

EID: 8844224197     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.48.168     Document Type: Article

References (29)

1. Yoshida, M., Takamatsu, J., Yoshida, S., et al. (1998) Effects of Boi-ogi-to treatment on visceral fat obesity in patients with diabetes mellitus. Jpn. J. Oriental Med., 49, 249-256.
2. Rerup, C. and Tarding, F. (1969) Streptozotocin and alloxan-induced diabetes in mice. Eur. J. Clin. Pharmacol., 7, 89-96.
3. Gokhale, M. S., Shah, D. H., Hakim, Z., Santani, D. D. and Goyal, R. K. (1998) Effect of chronic treatment with amilodipine in non-insulin-dependent diabetic rats. Pharmacol. Res., 37, 455-459.
4. Movassat, J. and Portha, B. (1999) Beta-cell growth in the neonatal Goto-Kakizaki rat and regeneration after treatment with streptozotocin at birth. Diabetologia, 42, 1098-1106.
5. Pele-Tounian, A., Wang, X., Rondu, F., Lamouri, A., Touboul, E., Marc, S., Dokhan, R., Pfeiffer, B., Manechez, D., Renard, R., Guardiola-Lemaitre, B., Godfroid, J. J., Penicaud, L. and Ktorza, A. (1998) Potent antihyperglycemic property of a new imidazolone derivative S-22068 (PMS 847) in a rat model of NIDDM. Br. J. Pharmacol., 124, 1591-1596.
6. Ikemoto, T., Akiyoshi, M., Fujitani, S., Okazaki, K., Kondo, N. and Maki, T. (1997) Hypoglycemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166). Br. J. Pharmacol., 120, 137-145.
7. Nakashima, N., Kimura, I. and Kimura, M. (1993) Isolation of pseudoprototimosaponin AIII from rhizomes of anemarrhena asphodeloides and its hypoglycemic activity in streptozotocin-induced diabetic mice. J. Nat. Prod., 56, 345-350.
8. Liu, Y. Y., Kobayashi, S., Makizumi, K., Kontani, H. and Tsutsumi, T. (1999) Hypoglycemic effect of Fang-ji-huang-qi-tang in streptozotocin-induced diabetic mice. J. Oriental Med., 49, 607-615.
9. Gonzalez, R. G., Barnett, P., Aguayo, J. and Chylack, L. T. J. (1984) Direct measurement of polyol pathway activity in the ocular lens. Diabetes, 33, 196-199.
10. Kinoshita, J. H. and Nishimura, C. (1988) The involvement of aldose reductase in diabetic complications. Diabetes Metab. Rev., 4, 323-337.
11. Yagihashi, S., Yamagishi, S., Wada, R. and Kokai, Y. (1996) Galactosemic neuropathy in transgenic mice for human aldose reductase. Diabetes, 45, 56-59.
12. Yamaoka, T., Nishimura, C. and Kokai, Y. (1995) Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia, 38, 255-261.
13. Nishimura, C., Lou, M. F. and Kinoshita, J. H. (1987) Depletion of myo-inositol and amino acids in galactosemic neuropathy. J. Neurochem., 49, 290-295.
14. Yabe, C. (1998) Aldose reductase in the polyol pathway. Folia Pharmacol. Jpn., 111, 137-145.
15. Yamamoto, Y., Yamagishi, S., Yonekura, H., Doi, T., Tsuji, H., Kato, I., Takasawa, S., Okamoto, H., Abedin, J., Tanaka, N., Sakurai, S., Migita, H., Unoki, H., Wang, H., Zenda, T., Wu, P. S., Segawa, Y., Higashide, T., Kawasaki, K. and Yamamoto, H. (2000) Roles of the AGE-RAGE system in vascular injury in diabetes. Ann. N.Y. Acad. Sci., 902, 163-170.
16. Kaji, T., Miyajima, S., Yamamoto, C., Fujiwara, Y., Sakurai, S., Yamagishi, S., Sueishi, K. and Yamamoto, H. (2000) Selective increase in decorin core mRNA level in cultured vascular smooth muscle cells after exposure to advanced glycation endproducts. J. Health Sci., 46, 223-227.
17. Hotta, N. (1997) New concepts and insights on the pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition. Nagoya J. Med. Sci., 60, 89-100.
18. Liu, Y. Y., Kobayashi, S., Kontani, H. and Tsutsumi, T. (1999) Hypoglycemic effect of Fang-ji-huang-qi-tang in streptozotocin-induced diabetic mice. J. Oriental Med., 49, 607-615.
19. Liu, Y. Y., Kobayashi, S., Tsutsumi, T. and Kontani, H. (2000) Combined effects of Stephania Radix and Astragali Radix in antihyperglycemic action of Boiogi-to (Fang-ji-huang-qi-tang) in streptozotocin-induced diabetic mice. J. Traditional Med., 17, 253-260.
20. Zhang, C., Kuhara, T. and Matsumoto, I. (1996) Simultaneous determination of sugars and sugar alcohols and its application in the study of diabetes mellitus by GC/MS. J. Kanazawa Med. Univ., 21, 399-410.
21. Tetsuo, M., Zhang, C., Motsmoto, H. and Motsmoto, I. (1999) Gas chromatographic-mass spectrometric analysis of urinary sugar and sugar alcohols during pregnancy. J. Chromatography B, 731, 111-120.
22. Greene, D. A. and Lattimer, S. A. (1986) Biochemical alteration and complications in diabetes. Clin. Chem., 32, 42-47.
23. Taylor, S. I. (1995) Diabetes Mellitus. In Handbook of The Metabolic and Molecular Bases of Inherited Disease (7th ed.: Scriver, Charles R., Beaudet, Arthur L., Sly, William S., Eds.), McGraw-Hill, Inc., New York, pp. 843-896.
24. Gabbay, K. H. (1973) The sorbitol pathway and the complications of diabetes. N. Engl. J. Med., 288, 832-836.
25. Sakamoto, N., Kinoshita, J. H. and Hotta, N. (1988) Polyol pathway and its role in diabetic complications. Excerpta Medica, Amsterdam.
26. Williamson, J. R., Chang, K., Frangos, M., et al. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes, 42, 801-813.
27. Cameron, N. E. and Cotter, M. A. (1994) The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab. Rev., 10, 189-224.
28. Nathan, D. M. (1993) Long-term complications of diabetes mellitus. N. Engl. J. Med., 328, 1676-1685.
29. Stevens, M. J., Feldman, E. L. and Greene, D. A. (1995) The etiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabetic Med., 12, 566-579.